Moreover, there was no significant difference in the ratio of liver weight to body weight between GSTM2 KO and WT mice (Supplementary Fig
From a clinical standpoint, this matters enormously because visceral fat is metabolically active and inflammatory, increasing risk for cardiovascular disease, type 2 diabetes, and insulin resistance
confidence allows consistent work
This intra-company comparison is particularly interesting because it reveals Novo Nordisk's multi-pronged strategy for next-generation obesity therapy
Clinical Update 10/17/2023 Honey for Acid Reflux
Neither the total (sample size: 331 in the GLP-1 receptor agonists group and 230 in the placebo group) nor the subtotal (sample size: 247 and 159 in early PD and 84 and 71 in late PD, in the GLP-1 receptor agonists group and placebo group, respectively) improvements related to GLP-1 receptor agonists were significant (MD = 1.32